Neutrophil to lymphocyte ratio: another drop in the ocean of CRPC biomakers?

Affiliations

¹ Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid; Centro Integral Oncológico Clara Campal (CIOCC), Madrid.
² OncoMIR Training Program, Spanish National Cancer Research Centre (CNIO), Madrid; Medical Oncology Department, Hopsital Universitario de Salamanca, Salamanca, Spain.
³ Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid; Centro Integral Oncológico Clara Campal (CIOCC), Madrid. Electronic address: dolmos@cnio.es.

Free article

Editorial

E Castro et al. Ann Oncol. 2015 Apr.

Free article

. 2015 Apr;26(4):622-623.

doi: 10.1093/annonc/mdv042. Epub 2015 Feb 2.

¹ Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid; Centro Integral Oncológico Clara Campal (CIOCC), Madrid.
² OncoMIR Training Program, Spanish National Cancer Research Centre (CNIO), Madrid; Medical Oncology Department, Hopsital Universitario de Salamanca, Salamanca, Spain.
³ Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid; Centro Integral Oncológico Clara Campal (CIOCC), Madrid. Electronic address: dolmos@cnio.es.

No abstract available

Comment on

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.
van Soest RJ, Templeton AJ, Vera-Badillo FE, Mercier F, Sonpavde G, Amir E, Tombal B, Rosenthal M, Eisenberger MA, Tannock IF, de Wit R. van Soest RJ, et al. Ann Oncol. 2015 Apr;26(4):743-749. doi: 10.1093/annonc/mdu569. Epub 2014 Dec 15. Ann Oncol. 2015. PMID: 25515657 Clinical Trial.
Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use.
Lorente D, Mateo J, Templeton AJ, Zafeiriou Z, Bianchini D, Ferraldeschi R, Bahl A, Shen L, Su Z, Sartor O, de Bono JS. Lorente D, et al. Ann Oncol. 2015 Apr;26(4):750-755. doi: 10.1093/annonc/mdu587. Epub 2014 Dec 23. Ann Oncol. 2015. PMID: 25538172 Clinical Trial.